SCHEMBL5588017

SCHEMBL5588017

CCCc1cc(O)c(O)c(C(=O)O)c1OCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 4/20 0.50
PTPN11 Q06124 3/20 0.50
PTPN2 P17706 2/20 0.44
PRKCI P41743 1/20 0.40
LDHA P00338 2/20 0.39
LDHB P07195 2/20 0.39
DAGLA Q9Y4D2 1/20 0.38
PPARG P37231 2/20 0.37
PPARA Q07869 2/20 0.37
BID P55957 3/20 0.36
MCL1 Q07820 3/20 0.36
BCL2L1 Q07817 2/20 0.36
BAK1 Q16611 2/20 0.36
KAT8 Q9H7Z6 2/20 0.36
EP300 Q09472 1/20 0.36
KAT2A Q92830 1/20 0.36
KAT2B Q92831 1/20 0.36
KAT5 Q92993 1/20 0.36
SAE1 Q9UBE0 1/20 0.36
METAP2 P50579 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5590309 0.91 BID (0.43) PTPN1PTPN11DAGLAPPARGPPARA
SCHEMBL5588073 0.90 PPARA (0.49) PTPN1DAGLAPPARGPPARABID
SCHEMBL5588765 0.90 PTPN1 (0.49) PTPN1PTPN11PTPN2PRKCILDHA
SCHEMBL5588241 0.89 METAP2 (0.40) PTPN1PTPN11PTPN2BCL2L1METAP2
SCHEMBL5587468 0.89 BID (0.51) PTPN1DAGLAPPARGPPARABID
SCHEMBL5587006 0.89 BID (0.51) PTPN1DAGLAPPARGPPARABID
SCHEMBL5588065 0.89 BID (0.51) PTPN1DAGLAPPARGPPARABID
SCHEMBL5589742 0.89 BID (0.51) PTPN1DAGLAPPARGPPARABID
SCHEMBL5590353 0.89 BID (0.51) PTPN1DAGLAPPARGPPARABID
SCHEMBL5587501 0.87 PTPN1 (0.47) PTPN1PTPN11PTPN2PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 PTPN1 4679/4885PTPN11 4354/4885PTPN2 4756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.